Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fagioli

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cancer|May 20, 2009
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patientsM Berger, Berger Massimo, G Grignani, et al.
Human Reproduction (Oxford, England)|September 16, 2021
Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working PartyT Diesch-Furlanetto, A Rovó, J E Galimard, et al.
Bone Marrow Transplantation|February 19, 2002
Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemiaA Balduzzi, M G Valsecchi, D Silvestri, et al.
Clinical Pharmacokinetics|July 18, 2019
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaJulie M Janssen, T P C Dorlo, D Niewerth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumoursR Luksch, G Grignani, F Fagioli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocolS Ferrari, K Sundby Hall, R Luksch, et al.
Bone Marrow Transplantation|March 20, 2026
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registryZ Szmit, G Lucchini, A Bertaina, et al.
Haematologica|June 19, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
Haematologica|March 28, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
British Journal of Cancer|October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessmentU Thiel, E Koscielniak, F Blaeschke, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cancer|May 20, 2009
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patientsM Berger, Berger Massimo, G Grignani, et al.
Human Reproduction (Oxford, England)|September 16, 2021
Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working PartyT Diesch-Furlanetto, A Rovó, J E Galimard, et al.
Bone Marrow Transplantation|February 19, 2002
Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemiaA Balduzzi, M G Valsecchi, D Silvestri, et al.
Clinical Pharmacokinetics|July 18, 2019
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaJulie M Janssen, T P C Dorlo, D Niewerth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumoursR Luksch, G Grignani, F Fagioli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocolS Ferrari, K Sundby Hall, R Luksch, et al.
Bone Marrow Transplantation|March 20, 2026
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registryZ Szmit, G Lucchini, A Bertaina, et al.
Haematologica|June 19, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
Haematologica|March 28, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
British Journal of Cancer|October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessmentU Thiel, E Koscielniak, F Blaeschke, et al.
Pageof 13